Abstract:Vascular endothelial growth factor (VEGF) represents a growth factor with important pro-angiogenic activity, having a mitogenic and an anti-apoptotic effect on endothelial cells, increasing the vascular permeability, promoting cell migration, etc. Due to these effects, it actively contributes in regulating the normal and pathological angiogenic processes. In humans, the VEGF family is composed of several members: VEGF-A (which has different isoforms), VEGF-B, VEGF-C, VEGF-D, VEGF-E (viral VEGF), VEGF-F (snake venom VEGF), placenta growth factor (PlGF), and, recently, to this family has been added endocrine gland-derived vascular endothelial growth factor (EG-VEGF). VEGF binds to tyrosine kinase cell receptors (VEGFRs): VEGFR-1 [Fms-like tyrosine kinase 1 (Flt-1)], VEGFR-2 [kinase insert domain receptor (KDR) in human; fetal liver kinase 1 (Flk-1) in mouse] and VEGFR-3 [Fms-like tyrosine kinase 4 (Flt-4)]. While VEGFR-1 and VEGFR-2 are expressed predominantly on vascular endothelial cells, VEGFR-3 is expressed especially on lymphatic endothelial cells. VEGFR-2 has the strongest pro-angiogenic activity and a higher tyrosine kinase activity than VEGFR-1. Endothelial cells also express co-receptors, such as neuropilin-1 (NP-1) and neuropilin-2 (NP-2), which modulate tyrosine kinase receptor activity. Both VEGF and VEGFRs are expressed not only on endothelial cells, but also on non-endothelial cells. This article aims to highlight the most recent data referring to the VEGF family and its receptors, as well as its implications in the angiogenesis process. At present, blocking angiogenesis in cancer or in other pathological processes, using anti-VEGF and anti-VEGFRs therapies, is considered to be extremely important.

Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance

Vascular Endothelial Growth Factor and Atherosclerosis

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Vascular endothelial growth factor (VEGF) signaling in tumor progression

Vascular endothelial growth factor signaling in development and disease

Tumor Angiogenesis and Signal Transduction Via Vascular Endothelial Growth Factor Receptor

Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role

VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels

VEGF in Signaling and Disease: Beyond Discovery and Development

The biology of VEGF and its receptors

The Role of the VEGF Signaling Pathway in Tumor Angiogenesis

The Impact of VEGF on Cancer Metastasis and Systemic Disease.

Biology and therapeutic targeting of vascular endothelial growth factor A

Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis

VEGF in biological control

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases

Lymphangiogenesis in cancers:a therapy target

Vascular Endothelial Growth Factor-B: Impact on Physiology and Pathology.

Non-angiogenic functions of vascular endothelial growth factor]